- Sai Life Sciences IPO Listing: CRDMO player ends at ₹765, a 40% jump from its IPO price CNBCTV18
- Sai Life Sciences shares jump 16% post listing. Should you buy, sell or hold? The Economic Times
- Sai Life Sciences IPO Allotment: Check status, GMP, likely listing price Business Standard
- Sai Life Sciences debuts on Dalal Street with 18% premium to issue price The Financial Express
- Sai Life Sciences, Purple United Sales Supreme Facility Management IPO Listing highlights: Sai Life Sciences stock ends 40% higher over issue price BusinessLine
Sai Life Sciences IPO Listing: CRDMO player ends at ₹765, a 40% jump from its IPO price CNBCTV18Sai Life Sciences shares jump 16% post listing. Should you buy, sell or hold? The Economic TimesSai Life Sciences IPO Allotment: Check status, GMP, likely listing price Business StandardSai Life Sciences debuts on Dalal Street with 18% premium to issue price The Financial ExpressSai Life Sciences, Purple United Sales Supreme Facility Management IPO Listing highlights: Sai Life Sciences stock ends 40% higher over issue price BusinessLine Top stories – Google News